The benefits of joining the Lab2Launch Community

Available lab spaces

  • 48 lab benches in an open Biosafety level 1 lab
  • 6 flexible & shared procedure rooms
  • 3 Novel Technology private suites (ranging from 400 to 700 sq.ft.)
  • 2 main shared equipment corridors outfitted with a cold room
  • 1 fume hood alcove
Lab2Launch is equipped with top-of-the-line instrumentation. Users will also have access to state-of-the- art core facilities at Emory, including but not limited to tissue culture, flow cytometry, and mass spec.


  • 22 dedicated desks in a shared workstations area
  • Kaldi’s Café
  • Shared Breakroom
  • Bike Storage Room
  • Commuter Shower Facilities
  • Lactation Rooms
  • Collaboration Areas
  • Reservable event/meeting spaces
  • Outdoor plaza with seating

Application process

Companies interested in participating in Lab2Launch will apply for admittance and provide:

  • Current business plan
  • Financial statements including balance sheet and income statement
  • Statement of ownership of Company
  • Names of members of board of directors (or board of managers)
  • Employment data including names of employees

Faculty associated with applicant companies must complete all Emory University intellectual property and conflict of interest disclosures and approvals. Company will enter into a Space Use License Agreement with Emory. Company must comply with all local, state, and federal laws and regulations as well as Emory University policies and procedures regarding environmental health and safety (EHSO) and, where appropriate, policies and procedures related to animal care, use of human subjects, embryonic stem cells, other biomaterials, etc. Company must maintain liability insurance as described in the Space Use License Agreement. Company will participate in annual progress review process. Rate sheet available upon request.

Health Sciences Research Building II Innovation Floor

"In my experience, you need to create new companies to take scientific discoveries from the laboratory to the clinic. These highly-focused, entrepreneurial enterprises can move more quickly and more cheaply from discovery to development than larger, more complex pharmaceutical companies. I believe that the modern tools and extensive resources available through the Innovation Floor will accelerate the ability of start-up companies to transform laboratory discoveries into drugs that prevent, treat and, ultimately, cure life-threatening diseases."

Raymond F. Schinazi